United KingdomLara Vivo, a 41-year-old supermarket store assistant from Bournemouth, began experiencing headaches and visual disturbances in early 2019, initially attributing them to stress. After noticing 'flickering lights' during work meetings, she sought an eye exam, expecting to need glasses. Instead, she was urgently referred to an emergency eye unit where she was diagnosed with uveal melanoma, a rare form of eye cancer. She underwent three costly surgeries in Barcelona, resulting in 10% vision in her affected eye. Despite remaining cancer-free for seven years, the disease returned in January 2026, spreading to her liver. NHS doctors confirmed the cancer was incurable and stated private chemosaturation therapy, which could target the liver tumor, is not available on the NHS due to cost-effectiveness concerns. Lara is now raising £120,000 through a crowdfunding campaign to access this treatment, emphasizing the lack of NHS support for advanced therapies.
Bias read (Progressive): The article highlights systemic failures in the UK's healthcare system, particularly the NHS, regarding access to advanced treatments like chemosaturation therapy. The emphasis on the unavailability of such treatments on the NHS, coupled with the personal struggle of a patient, frames the issue as a
